Cord Blood-Derived Macrophage-Lineage Cells Rapidly Stimulate Osteoblastic Maturation in Mesenchymal Stem Cells in a Glycoprotein-130 Dependent Manner

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Fernandes, Tania J ^a,b   Hodge, Jason M ^a,b,c   Singh, Preetinder P ^d   Eeles, Damien G ^d,e   Collier, Fiona M ^b,c   Holten, Ian ^f   Ebeling, Peter R ^a   Nicholson, Geoffrey C ^a,g   Quinn, Julian M W ^d,h  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GEELONG HOSPITAL   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f Department of Plastic Surgery Barwon Health ^*  (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN 2; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; GAMMA INTERFERON; GLYCEROL 2 PHOSPHATE; GLYCOPROTEIN GP 130; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; ONCOSTATIN M; OSTEOCLAST DIFFERENTIATION FACTOR; WNT3A PROTEIN;

ARTICLE; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MACROPHAGE ACTIVATION; MESENCHYMAL STEM CELL; NORMAL HUMAN; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

CELLS, CULTURED; FETAL BLOOD; FLOW CYTOMETRY; GLYCOPROTEINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84884200196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073266     Document Type: Article

References (39)

1. Long F, (2012) Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 13: 27-38.
2. Lee RH, Kim B, Choi I, Kim H, Choi HS, et al. (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14: 311-324.
3. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
4. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
5. Hattori H, Sato M, Masuoka K, Ishihara M, Kikuchi T, et al. (2004) Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs 178: 2-12.
6. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF, (1997) Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15: 546-557.
7. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
8. Seong JM, Kim BC, Park JH, Kwon IK, Mantalaris A, et al. (2010) Stem cells in bone tissue engineering. Biomed Mater 5: 062001.
9. Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, et al. (1996) Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 88: 4029-4039.
10. Ash P, Loutit JF, Townsend KM, (1980) Osteoclasts derived from haematopoietic stem cells. Nature 283: 669-670.
11. Scheven BA, Visser JW, Nijweide PJ, (1986) In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321: 79-81.
12. Martin TJ, Quinn JM, Gillespie MT, Ng KW, Karsdal MA, et al. (2006) Mechanisms involved in skeletal anabolic therapies. Ann N Y Acad Sci 1068: 458-470.
13. Tang Y, Wu X, Lei W, Pang L, Wan C, et al. (2009) TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15: 757-765.
14. Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, et al. (2008) Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 181: 1232-1244.
15. Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, et al. (2010) Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116: 4815-4828.
16. Alexander KA, Chang MK, Maylin ER, Kohler T, Muller R, et al. (2011) Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 26: 1517-1532.
17. Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, et al. (2009) Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 24: 1572-1585.
18. Hodge JM, Kirkland MA, Aitken CJ, Waugh CM, Myers DE, et al. (2004) Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF. J Bone Miner Res 19: 190-199.
19. Aitken CJ, Hodge JM, Nishinaka Y, Vaughan T, Yodoi J, et al. (2004) Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling. J Bone Miner Res 19: 2057-2064.
20. Hodge JM, Kirkland MA, Nicholson GC, (2007) Multiple roles of M-CSF in human osteoclastogenesis. J Cell Biochem 102: 759-768.
21. Quinn JM, Elliott J, Gillespie MT, Martin TJ, (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139: 4424-4427.
22. Guihard P, Danger Y, Brounais B, David E, Brion R, et al. (2012) Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 30: 762-772.
23. Nicolaidou V, Wong MM, Redpath AN, Ersek A, Baban DF, et al. (2012) Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One 7: e39871.
24. Quinn JM, Sims NA, Saleh H, Mirosa D, Thompson K, et al. (2008) IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. J Immunol 181: 5720-5729.
25. Mosser DM, (2003) The many faces of macrophage activation. J Leukoc Biol 73: 209-212.
26. Quinn JM, Morfis M, Lam MH, Elliott J, Kartsogiannis V, et al. (1999) Calcitonin receptor antibodies in the identification of osteoclasts. Bone 25: 1-8.
27. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ, (1995) Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
28. Korchynskyi O, ten Dijke P, (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
29. Allan EH, Hausler KD, Wei T, Gooi JH, Quinn JM, et al. (2008) EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res 23: 1170-1181.
30. Passlick B, Flieger D, Ziegler-Heitbrock HW, (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
31. Tacke F, Randolph GJ, (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618.
32. Song HY, Jeon ES, Kim JI, Jung JS, Kim JH, (2007) Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 101: 1238-1251.
33. Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, et al. (1995) The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate-is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16: 603-610.
34. Walker EC, McGregor NE, Poulton IJ, Solano M, Pompolo S, et al. (2010) Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest 120: 582-592.
35. Walker EC, Poulton IJ, McGregor NE, Ho PW, Allan EH, et al. (2012) Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. J Bone Miner Res 27: 902-912.
36. Minehata K, Takeuchi M, Hirabayashi Y, Inoue T, Donovan PJ, et al. (2006) Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow. Int J Hematol 84: 319-327.
37. Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, et al. (2004) Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 113: 379-389.
38. Sims NA, (2009) gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice. Mol Cell Endocrinol 310: 30-39.
39. Saleh H, Eeles D, Hodge JM, Nicholson GC, Gu R, et al. (2011) Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology 152: 1911-1922.